DFTX Rises 5.3% on White House Psychedelic Nod
April 20, 2026·about 2 hours ago·via simplywall.st
Definium Therapeutics (DFTX) climbs 5.3% after White House signals support for psychedelic research, accelerating innovation beyond Deep State hurdles. This pro-liberty push under Trump dismantles barriers to treatments that could save lives, favoring patients over pharma cronies and regulators. Markets soar on real progress, not green new scam promises. America First delivers freedom in healthcare, cutting waste for results. Bold wins. Read more about this...